Predictive and Prognostic Significance of p27, Akt, PTEN and PI3K Expression in HER2-Positive Metastatic Breast Cancer

Okutur, Kerem; Bassulu, Nuray; Dalar, Levent; Aydin, Kubra; Bozkurt, Mustafa; Pilanci, Kezban Nur; Dogusoy, Gulen Bulbul; Tecimer, Coskun; Mandel, Nil Molinas; Demir, Gokhan

추천

검색

자료유형: 학술저널

저자정보: Okutur, Kerem (Department of Medical Oncology, Acibadem University School of Medicine) Bassulu, Nuray (Department of Pathology, Istanbul Bilim University School of Medicine) Dalar, Levent (Department of Chest Disease, Istanbul Bilim University School of Medicine) Aydin, Kubra (Ankara Oncology Training and Research Hospital) Bozkurt, Mustafa (Department of Medical Oncology, Acibadem University School of Medicine) Pilanci, Kezban Nur (Istanbul Bilim University School of Medicine) Dogusoy, Gulen Bulbul (Department of Pathology, Istanbul Bilim University School of Medicine) Tecimer, Coskun (Istanbul Bilim University School of Medicine) Mandel, Nil Molinas (Department of Medical Oncology, Koc University School of Medicine) Demir, Gokhan (Department of Medical Oncology, Acibadem University School of Medicine)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제16권 제7호

발행연도: 2015.1

수록면: 2,645 - 2,651 (7page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Background: The phosphatidylinositol 3'-kinase/Akt (PI3K/Akt) pathway is a key regulator for HER2-overexpressing breast cancer, but data about whether activation of PI3K/Akt is associated with poor prognosis and resistance to trastuzumab therapy is controversial. In this study we investigated predictive and prognostic significance of expression of p27, Akt, PTEN and PI3K, which are components of the PI3K/Akt signaling pathway, in HER2-positive metastatic breast cancer (MBC), retrospectively. Materials and Methods: Fifty-four HER2-positive MBC patients who had received first-line trastuzumab-based therapy were recruited for the study group. All of the patient's breast tissue samples were examined for p27 and Akt expression. In addition, twenty-five patients with sufficient amount of tumor tissue were also examined for PTEN and PI3K expression. p27, Akt, PTEN and PI3K were evaluated by immunohistochemistry and their relationship with patient demographic features, tumor characteristics, response to trastuzumab-based treatment and survival outcomes were analyzed. Results: p27, Akt, PTEN and PI3K were positive in 25.9%, 70.4%, 24% and 96% of the cases, respectively. Nomne were significantly associated with response to trastuzumab and time to progression (TTP). A trend toward statistical significance for longer overall survival (OS) was found for PTEN-positive patients (p=0.058); there was no significant relationship between the other immunohistochemical variables and OS. When we analyzed groups regarding co-expression, the PTEN-negative/Akt-negative group had a significantly lower objective response rate (ORR) (20% vs 80%, p=0.023) and the PTEN-negative/p27-negative and PTEN-negative/Akt-negative groups had significantly lower median OS compared to other patients (26.4 months vs 76.1 months, p=0.005 and 25.6 months vs 52.0 months, p=0.007, respectively). Conclusions: p27, Akt, PTEN and PI3K expression is not statistically significantly associated with ORR, TTP and OS, individually. However, the combined evaluation of p27, Akt and PTEN could be helpful to predict the response to trastuzumab-based therapy and prognosis in HER2-positive MBC.

#Breast cancer #HER2, p27 #Akt #PTEN #trastuzumab #response to therapy

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!